Guj HC: Depression can be classified as serious illness

Ahmedabad (PTI) Depression can be classified as a serious illness, especially in the context of the COVID-19 pandemic, the Gujarat High Court has observed, while setting aside the cancellation of registration and admission of an engineering student by a government college for not appearing for requisite exams due to depression and suicidal thoughts.

The court issued the order on August 31 and a copy of it was made available on Thursday.

The academic performance review committee of the Surat-based Sardar Vallabhbhai National Institute of Technology (SVNIT) in October 2020 cancelled the registration and admission of the first-year B Tech (Bachelor of Technology) student, for not earning 25 credits needed for getting promoted to the next semester.

The student challenged this in the HC on the ground that he had suffered from “severe depressive episodes with suicidal ideation“, which started in January 2020 and peaked in May-June last year due to the COVID-19 pandemic situation, which is why he could not appear for the examination.

“In the facts and circumstances of the case and more particularly in the context of the currency of the pandemic period, the depressive state of mind and the depression created in the petitioner student, can be classified as serious illness,” the court of Justice N V Anjaria observed.

The depressive cycle which the petitioner suffered was during the period of COVID-19 pandemic itself. It was a period of wide-spread despondency, the court noted. PTI

  • Related Posts

    • Pharma
    • July 22, 2025
    • 114 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    • Pharma
    • July 16, 2025
    • 542 views
    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug